DSM and JLL form $2-billion pharma services firm by merging DSM Pharmaceutical Products with Patheon
07:06 AM | November 19, 2013 | Deepti Ramesh
DSM and JLL Partners (New York), a middle-market private equity firm, will create a new company, which will be a leading, global contract development and manufacturing organization (CDMO) for the...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.